Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-alpha and melphalan.
Häffner
A C
AC
Zepter
K
K
Fritz
T
T
Dummer
R
R
Lejeune
F J
FJ
Burg
G
G
D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D005260:Female; D006801:Humans; D007866:Leg / Q000473:pathology; D007890:Leiomyosarcoma / Q000188:drug therapy* / Q000473:pathology; D008558:Melphalan / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D018906:Antineoplastic Agents, Alkylating; D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan